A study to evaluate an oral medication, Siponimod (BAF312), in patients with Secondary Progressive Multiple Sclerosis

A study to evaluate an oral medication, Siponimod (BAF312), in patients with Secondary Progressive Multiple Sclerosis
Recruiting
18 years - 60 years
All
Phase 3
1 Location

Brief description of study

The main purpose of the study is to see how effective and safe BAF312 is compared to a Placebo in patients with Secondary Progressive MS. A placebo is a “pill” (capsule or tablet) with no medicine inside. A placebo is used to make sure that the changes you report are just not happening by chance, ex. by comparing the results in patients taking BAF312 to those in patients taking placebo. By participating in this trial, you will either receive BAF312 or a Placebo.

Detailed description of study

This study includes 3 parts: 1. A screening phase- to see if you are eligible to participate in this study, 2. A study drug/placebo treatment phase- this will include visits (which will occur every three months after the Day 1, Day 7 and Day 28 visits) that will monitor you throughout the study while taking the study drug or placebo, and 3. A follow-up phase, which will include safety assessments, but will not involve the administration of study drug or placebo.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Multiple sclerosis,Secondary Progressive
  • Age: 18 years - 60 years
  • Gender: All


Updated on 19 Feb 2024. Study ID: 819215

Find a site

Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Race
Ethnicity
Other language

Message For Non Enrolling By Invitation Trial

Select a study center that’s convenient for you, and get in touch with the study team.